MS Sandhu, AH Heald, JM Gibson, JK … - The Lancet, 2002 - Elsevier At 4·5 years of follow-up, 51 (8%) of 615 participants developed impaired
glucose tolerance or type-2 diabetes. After adjustment for correlates of IGF-I
and risk factors for glucose intolerance, the odds ratio for risk of ... Cited by 211 - Related articles - All 6 versions
- ►nih.gov GMN Behrens, AR Boerner, K Weber, J van … - Journal of Clinical Investigation, 2002 - Am Soc Clin Investig Insulin resistance is a frequently observed side effect of highly active
antiretroviral therapy (HAART). Currently, very little is known about the
mechanisms or specific tissues involved. We aimed to identify possible ... Cited by 67 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org N Stefan, AM Hennige, H Staiger, J Machann, F … - Diabetes Care, 2006 - Am Diabetes Assoc OBJECTIVE—The α 2 -Heremans-Schmid glycoprotein (AHSG; fetuin-A in animals)
impairs insulin signaling in vitro and in rodents. Whether AHSG is associated
with insulin resistance in humans is under investigation. In an animal ... Cited by 60 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org L Monnier, C Colette, R Rabasa-Lhoret, H … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—In the population considered as a whole, prelunch glucose
concentrations (12.0 mmol/l) were found to be significantly increased (P <
0.0001) when compared with those observed at 8:00 am. (8.8 mmol/l), at 2:00 ... Cited by 54 - Related articles - BL Direct - All 5 versions
J Radziuk, S Pye - Diabetologia, 2002 - Springer The rate of endogenous glucose production (EGP) is important in understanding
the pathophysiology of Type II (non-insulin-dependent) diabetes mellitus, the
aetiology of its complications, and the identification of potential ... Cited by 34 - Related articles - BL Direct - All 4 versions
D Tripathy, KF Eriksson, M Orho-Melander, J … - Diabetologia, 2004 - Springer Aims/hypothesis. The aim of the study was to evaluate the relationship between
insulin sensitivity, beta cell function and glucose tolerance, and its
dependence on variants in the newly identified Type 2 diabetes sus- ... Cited by 35 - Related articles - BL Direct - All 4 versions
- ►diabetes.org.br [PDF] E Arbit - Diabetes Technology & Therapeutics, 2004 - liebertonline.com Insulin remains the most effective and durable drug in the armamentarium for the
treatment of advanced-stage diabetes. Nevertheless, clinical studies have shown
that even on insulin treatment, a significant percentage of patients fail ... Cited by 20 - Related articles - BL Direct - All 5 versions
O Tschritter, A Fritsche, N Stefan, M Haap, C … - Metabolism, 2003 - Elsevier The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor
(PPARγ 2 ) is associated with reduced risk for type 2 diabetes. Although
increased insulin sensitivity of glucose disposal and lipolysis has been ... Cited by 21 - Related articles - All 10 versions
ES Horton, JE Foley, SG Shen, MA Baron - Current Medical Research and Opinion®, 2004 - informahealthcare.com Objective: To assess the efficacy and tolerability of the combination of
nateglinide (120 mg, ac) and metformin (500 mg, tid) as initial treatment in
drug-naïve patients with type 2 diabetes mellitus (T2DM). Research design ... Cited by 19 - Related articles - BL Direct - All 7 versions
